×
Saturday, April 25, 2026
Get News Alerts
  • Home
  • False Claims
  • Johnson & Johnson Sued by Bayer Over Alleged False Claims on NUBEQA - marketscreener.com

Johnson & Johnson Sued by Bayer Over Alleged False Claims on NUBEQA - marketscreener.com

by MT Newswires
Mon, Feb 23, 2026 10:57 ET
in False Claims

JOHNSON & JOHNSON

Add to a listPDF Report

Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Real-time Estimate Cboe BZX 00:15:49 2026-02-23 pm EST 5-day change 1st Jan Change
246.07 USD +1.48% +1.11% +18.88%
1h Bayer sues Johnson & Johnson over marketing of prostate cancer drug RE
1h Johnson & Johnson Sued by Bayer Over Alleged False Claims on NUBEQA MT

Summary

Quotes

Charts

News

Company

Financials

Valuation

Consensus

Ratings

Calendar

Sector

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Johnson & Johnson Sued by Bayer Over Alleged False Claims on NUBEQA

Share

MT Newswires - 2026

Share

Latest news about Johnson & Johnson

...
1h Bayer sues Johnson & Johnson over marketing of prostate cancer drug RE
1h Johnson & Johnson Sued by Bayer Over Alleged False Claims on NUBEQA MT
1h Johnson & Johnson Sued by Bayer for Alleged False Claims on NUBEQA MT
1h Johnson & Johnson Sued by Bayer Over Alleged False Claims Regarding Nubeqa's Efficacy MT
1h EU Commission OKs New Dosing Options for J&J's Non-small Lung Cancer Treatment MT
1h Bayer files lawsuit against Johnson & Johnson, Janssen Biotech RE
4h Blackstone, J&J in Co-Funding Pact for Acute Myeloid Leukemia Drug DJ


Read Full Story: https://news.google.com/rss/articles/CBMiugFBVV95cUxNWXk0NnRXQ0VabFN5VUIwc1p3...


False Claims